EcoDrugPlus

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSOKIG00005038908
Gene Symbol: ATP4B
3 Cross references
183 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSOKIG00005012666
Gene Symbol: ATP1A1
3 Cross references
145 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSOKIG00005021527
Gene Symbol: ATP1A1
3 Cross references
212 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSOKIG00005027811
Gene Symbol: ATP1A1
3 Cross references
212 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSOKIG00005044610
Gene Symbol: ATP1A2A
1 Cross references
199 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSOKIG00005037072
Gene Symbol: ATP1B1
3 Cross references
218 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSOKIG00005044526
Gene Symbol: ATP1B1
3 Cross references
220 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSOKIG00005016648
Gene Symbol: ATP1B1
3 Cross references
222 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3b

Ensembl ID : ENSOKIG00005004318
Gene Symbol: ATP1B3B
1 Cross references
226 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSOKIG00005019473
Gene Symbol: ATR
3 Cross references
197 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSOKIG00005010973
Gene Symbol: AXL
3 Cross references
181 Possible Orthologues:

B1 Bradykinin Receptor-Like

Ensembl ID : ENSOKIG00005024735
Gene Symbol: LOC109903214
3 Cross references
144 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).